Results 311 to 320 of about 26,046,977 (327)

Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection

Journal of gastroenterology, 2017
J. Toyota, Y. Karino, F. Suzuki, F. Ikeda, A. Ido, Katsuaki Tanaka, K. Takaguchi, A. Naganuma, E. Tomita, K. Chayama, S. Fujiyama, Yukiko Inada, H. Yoshiji, Hideaki Watanabe, H. Ishikawa, Wenhua Hu, F. Mcphee, Misti Linaberry, P. Yin, E. Swenson, H. Kumada   +20 more
semanticscholar   +1 more source

Usher Syndrome Type 1: Genotype–Phenotype Relationships

Retina, 2005
Thomas B, Friedman, Julie M, Schultz, Zubair M, Ahmed   +2 more
openaire   +2 more sources

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan

Journal of Medical Virology, 2017
N. Akuta, H. Sezaki, F. Suzuki, Shunichiro Fujiyama, Y. Kawamura, T. Hosaka, M. Kobayashi, M. Kobayashi, S. Saitoh, Yoshiyuki Suzuki, Y. Arase, K. Ikeda, H. Kumada   +12 more
semanticscholar   +1 more source

In vitro Selection of Resistance to Sofosbuvir in HCV Replicons of Genotype-1 to -6

Antiviral Therapy, 2017
Simin Xu, B. Doehle, S. Rajyaguru, B. Han, O. Barauskas, Joy Y. Feng, Jason K. Perry, H. Dvory‐Sobol, E. Svarovskaia, Michael D. Miller, H. Mo   +10 more
semanticscholar   +1 more source

Caution with ?1-adrenergic receptor genotyping*1

Clinical Pharmacology & Therapeutics, 2004
openaire   +1 more source

Association between genetic polymorphisms (ACE genotype, PAI-1 genotype and MTHFR genotype) and coronary artery stenosis

Atherosclerosis, 2000
E. Okada, K. Oida, K. Asazuma, K. Eguchi, S. Kosaka, G. Tohda, S. Takahashi, H. Kimura, H. Yoshida, I. Miyamori   +9 more
openaire   +1 more source

Real-World Effectiveness and Predictors of Sustained Virological Response with All-Oral Therapy in 21,242 Hepatitis C Genotype-1 Patients

Antiviral Therapy, 2016
L. Backus, P. Belperio, T. A. Shahoumian, T. Loomis, L. Mole   +4 more
semanticscholar   +1 more source

Real‐world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment‐naive, genotype 1 hepatitis C‐infected patients

Hepatology, 2016
L. Backus, P. Belperio, T. A. Shahoumian, T. Loomis, L. Mole   +4 more
semanticscholar   +1 more source

Treatment With LedipasvirSofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

Annals of Internal Medicine, 2016
M. Colombo, A. Aghemo, Hong Liu, Jie Zhang, H. Dvory‐Sobol, R. Hyland, C. Yun, B. Massetto, D. Brainard, J. Mchutchison, Marc Bourlire, M. Peck‐Radosavljevic, M. Manns, S. Pol   +13 more
semanticscholar   +1 more source

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections.

Gastroenterology, 2016
E. Gane, C. Schwabe, R. Hyland, Yin Yang, E. Svarovskaia, L. Stamm, D. Brainard, J. Mchutchison, C. Stedman   +8 more
semanticscholar   +1 more source